康哲藥業(00867.HK)最新MSCI-ESG評級維持AA，位列全球同業領先水平
近日，全球最大指數公司MSCI（明晟，Morgan Stanley Capital International）更新了對康哲藥業控股有限公司（00867.HK）的ESG（環境、社會及管治）評級報吿，康哲藥業最新評級維持“AA”，超越83%的製藥行業公司，其ESG管理水平保持全球同業領先地位。
MSCI目前已對超過2900家全球企業進行ESG評級，由於其獨立性、一致性和公開性，其評級結果被視為全球投資機構投資決策的重要依據。MSCI ESG評級結果由高到低依次分為AAA、AA、A、BBB、BB、B、CCC七個等級。康哲藥業的MSCI ESG評級連續兩年保持“AA”級，且在企業治理、人力資本發展、產品安全與質量等多個領域得分遠超行業平均水平，體現了資本市場對其多維管治實踐與可持續發展價值的充分肯定。
康哲藥業始終高度重視ESG管治與實踐，以“貫徹環保理念，成就社會責任價值，致力於成為國內領先的可持續發展醫藥企業”為可持續發展目標。康哲藥業已於2020年在董事會層面設立ESG委員會，主動關注利益相關方訴求和全球ESG治理趨勢，由上至下持續推動內部運營的改善和提升，並積極參與公益慈善和環境保護實踐。公司堅持“以奮鬥者為本”的理念，將員工視為企業最寶貴的資產，為員工提供全面的發展通道，並積極維護員工權益。此外，作為醫藥行業領先企業，康哲藥業堅持“持續改進、質量至上”的產品質量方針，通過貫穿產品全生命週期的產品質量管控，以可及、可負擔、可信賴的品質藥物守護民眾健康。
康哲藥業表示：“未來，集團將繼續深入融合ESG管治與企業運營，履行企業環境和社會責任，以患者為中心，提供更多能夠滿足臨牀需求的高質量、可負擔的創新藥，為社會創造更多價值。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
